Shedding light on the dark side of upscheduling opioids
There’s a debate about whether introducing tighter restrictions on prescribing and dispensing opioids is a good thing. But it seems a strange debate because who would be suggesting otherwise?
However, researchers are saying that there’s evidence of unintended consequences with the approach, and not all of them are welcome.
In 2014, in the midst of the nation’s prescription opioid crisis, the US Drug Enforcement Administration rescheduled hydrocodone combinations, from a Schedule 3 controlled substance to the more restrictive Schedule 2, narrowing the clinical indications for use